Home Tags Drugs and Pharmaceuticals

Tag: Drugs and Pharmaceuticals

Pet King Brands Celebrates 20 Years as a Leader in the Pet Health Products Industry

WESTMONT, Ill. /ScoopCloud/ -- Pet health products company, Pet King Brands, Inc. - the maker of veterinarian-recommended brands ZYMOX(R) Dermatology and Oratene(R) Brushless Oral Care - celebrates 20 years of helping pets find relief from problematic ear, skin and mouth conditions.

Paragon BioTeck, Inc. Hosts Pearl Buck Preschool Holiday Event

PORTLAND, Ore. /ScoopCloud/ -- Paragon BioTeck announces holiday event, "A Night to Remember," scheduled Friday, Dec. 7, 2018 from 5:30 - 8 p.m. in Eugene, Ore. The event delivers a magical night of holiday sights and sounds for the families of Pearl Buck Preschool.

Leading Companies to Support C Diff Foundation 6th Annual International C.diff. Conference and Health EXPO, Nov. 8-9, Philadelphia

PHILADELPHIA, Pa. /ScoopCloud/ -- The C Diff Foundation is honored to welcome leading companies to the 6th Annual International "C.diff. Awareness Conference and Health EXPO," as they come together to make a global difference. These companies are dedicated to the prevention, diagnostics, treatments, environmental safety products and services focused on C.difficile infections and Healthcare-associated infections and whose role serves great importance in the C.diff. community.

Healthcare Tech Outlook Names Delta Care Rx a Top 10 Pharmacy Management Solution Provider

FREMONT, Calif. /ScoopCloud/ -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the "Top 10 Pharmacy Management Solution Providers of 2018," according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.

Alejandro Arboleda Named 2018 Koch Kellan Scholar

PORTLAND, Ore. /ScoopCloud/ -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.

C Diff Foundation Presents Award to CutisPharma in Recognition of Contribution to C. diff. Community

NEW PORT RICHEY, Fla. /ScoopCloud/ -- The C Diff Foundation today announced that it presented CutisPharma, Inc., its "Making a Difference" award as a special recognition of the significant contribution that CutisPharma has made to the C.diff. Community: helping the advancement of C.diff. awareness as well as expanding treatment options for C.diff. patients.

Delta Care Rx Now Integrates with Suncoast Electronic Medical Records

PITTSBURGH, Pa. /ScoopCloud/ -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.

ScriptDrop and Albertsons Hurricane Relief Efforts To Be Covered on ‘The Success Files’ with Rob Lowe

NASHVILLE, Tenn. /ScoopCloud/ -- ScriptDrop, a healthcare technology company providing medication reminders and deliveries while fighting prescription abandonment and abuse, today announced that it will be featured on "The Success Files" hosted by Rob Lowe, airing on MSNBC and PBS in 2018.

ECHO Connection – Cannabinoid-Based Education, Collaboration and Hope – Non-Profit Charitable Org Appoints New CEO Andrea Barnes

SAN DIEGO, Calif. /ScoopCloud/ -- ECHO Connection, a non-profit charitable organization dedicated to educating the world, hosting collaborative platforms, and providing hope for those in need of cannabinoid-based therapies, announced today that it has appointed Andrea Barnes as its new CEO and President. Barnes will be speaking about the charity's work in guiding families seeking the therapeutic effects of cannabinoids by connecting them with resources that can help at the 4th Annual Cannabis World Congress & Business Exposition (CWCBE) in Boston.

Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship

PORTLAND, Ore. /ScoopCloud/ -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.

Edmond Hooker, MD, Darrel Hicks, and Bruce Rippe Discuss Medical Mattress Contamination Issues on C.diff Spores and More, Aug. 1

TAMPA, Fla. /ScoopCloud/ -- C Diff Foundation's, "C. diff. Spores and More Global Broadcasting Network," is honored to announce Dr. Edmond Hooker, MD - Associate Professor of Health Services Administration at Xavier University, Darrel Hicks, a well-known hospital environment specialist and educator, and Bruce Rippe, CEO of Trinity Guardion, manufacturer of the Trinity Guardion Patient Protective Barrier, as our guest speakers on August 1, 2017.

ChemDiv Selected by Arcus Biosciences as the Sole Chemistry Provider for its Discovery Screening Collection

SAN DIEGO, Calif. /ScoopCloud/ -- ChemDiv Inc., a fully integrated California-based CRO, announced today that Arcus Biosciences selected ChemDiv as the sole source of molecules for Arcus's growing HTS screening collection. This collaboration, which utilized Arcus's medicinal chemistry knowledge and ChemDiv's computational and synthetic chemistry expertise, has resulted in the selection of several hundred thousand structures from which Arcus expects to identify starting points for several of the discovery programs in its portfolio.

Verify Smart Corporation Signs Letter of Intent to Acquire Equity Stake and Exclusive International Reseller Rights in Med-Con Technologies, LLC

FERNLEY, Nev. /ScoopCloud/ -- Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.

EPIC Insurance adds Reba Mathew, Pharm.D., R.Ph to Employee Benefits Consulting Pharmacy Practice

HOUSTON, Texas /ScoopCloud/ -- EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today that Reba Mathew Pharm.D., R.Ph has joined the firm's Employee Benefits Consulting Practice as Pharmacy Practice Director.

Medical Experts Unite Regarding Health Benefits of Testosterone Therapy in Women

IRVING, Texas /ScoopCloud/ -- BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women. The AMMG conference runs April 27-30, 2017 in Orlando, Florida.

Delta Care Rx Announces Patrick White, MD, Inaugural Recipient of Delta Distinguished Scholar Award

PITTSBURGH, Pa. /ScoopCloud/ -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.

Trump’s wrong attack on Opioid Epidemic

CORTE MADERA, Calif. /ScoopCloud/ -- Dr. Don Harte, chiropractic activist, says Trump's new panel, headed by Chris Christie, to deal with the opioid epidemic, is "philosophically and scientifically dead wrong." Dr. Harte declares, "The reason for this epidemic is clear. Orthopedists and other doctors freely prescribe Oxycontin, Fentanyl, Soma and other opioid drugs, get their patients addicted."

Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

PORTLAND, Ore., /ScoopCloud/ -- Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

BioTE Medical Poised to Change Healthcare as it Expands into Georgia

ATLANTA, Ga., May 11, 2016 (SEND2PRESS NEWSWIRE) -- BioTE(R) Medical, a leader in bioidentical hormone replacement therapy (BHRT), is expanding its nationwide network of certified physicians into the Atlanta, Georgia market this month.

W&L Hopes Faster FDA Publication of Potential Risk Signals for SGLT2 Inhibitors: Newest – Stroke, Thromboembolic Events, Acute Kidney Injury

NEW YORK, N.Y., April 1, 2016 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., said today it hopes potentially fatal side effects associated with SGLT2 inhibitor drugs will be reported to consumers faster, since people taking these next-generation diabetes medications deserve to be notified of the health dangers shortly after they have been reported to the U.S. Food and Drug Administration (FDA).

Paragon BioTeck Receives EN ISO 13485:2012 Certification

PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.

eAgile Announces the Production Launch of the eSeal RFID Solution for Sealed Caps and Closures

GRAND RAPIDS, Mich. and ZURICH, Switzerland, Jan. 26, 2016 (SEND2PRESS NEWSWIRE) -- eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announces the successful high-volume production launch of the eSeal heat induction solution. eSeal is the first turnkey solution engineered to integrate the benefits of RFID into the billions of caps and closures consumed by the over-the-counter pharmaceutical, nutraceutical, cosmetic and chemical manufacturers.

BioTE Medical Study Showing Promising Results for Military Veterans Diagnosed with PTSD and TBI

IRVING, Texas, Dec. 30, 2015 (SEND2PRESS NEWSWIRE) -- A current BioTE(R) Medical Combat Trauma Treatment Study (in conjunction with the Veterans Advocacy Center (VAC)) is showing promising results in helping veterans suffering from Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI).

Weitz and Luxenberg Adds Serious Urinary Tract Infections to SGLT2 Inhibitor Injuries Probe

NEW YORK, N.Y., Dec. 7, 2015 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., today announced that the firm has expanded the scope of its investigation into SGLT2 inhibitor drug injuries. SGLT2 inhibitor drugs include Invokana and others listed below. This move will allow the nationally known mass tort law and personal injury firm to focus on cases where people taking SGLT2 inhibitors were hospitalized after developing urosepsis (serious infection of the blood) or pyelonephritis (infection of the kidneys) from SGLT2 inhibitor-associated urinary tract infections.

Harbor Compounding Pharmacy Advises About Coverage for Compounded Medications During Open Enrollment 2016

COSTA MESA, Calif., Oct. 12, 2015 (SEND2PRESS NEWSWIRE) -- Many insurance plans are dropping coverage of compounded medications, but some insurance plans still do cover for these custom formulations. Harbor Compounding Pharmacy provides resources and referrals to patients to find insurance coverage for their compounded medications during open enrollment 2016.

E-VAI – the Artificial Intelligence Platform from Eularis Changes the Rules of the Marketing in Pharma

NEW YORK, N.Y. and Tokyo, Sept. 15, 2015 (SEND2PRESS NEWSWIRE) -- Eularis announces today the release of E-VAI, the latest development in sophisticated artificial intelligence technology delivering next generation analytics and decision making to Pharma marketers globally. E-VAI changes the game for marketers struggling to understand and get value from their marketing.

Zofran Birth Defect Cases Being Accepted by Weitz and Luxenberg

NEW YORK, N.Y., April 7, 2015 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., announced it is accepting cases of congenital heart defects and cleft facial abnormalities in children whose mothers took the prescription drug Zofran during pregnancy to relieve symptoms of morning sickness.

Weitz & Luxenberg’s Relkin Appointed to Xarelto MDL Leadership Team

NEW YORK, N.Y., Feb. 11, 2015 (SEND2PRESS NEWSWIRE) -- Ellen Relkin, of counsel attorney with Weitz and Luxenberg, P.C., has been named to the plaintiffs' steering committee created by judicial order to facilitate lawsuits against the makers of the anticoagulant drug Xarelto, the personal injury and mass tort law firm today announced.